SmPC - Anastrozole 1mg Film-coated Tablets: Change history
View Summary of Product Characteristics (SmPC - Anastrozole 1mg Film-coated Tablets)
Last updated on this site: 09 Nov 2023
Description of update: Repurposing project to add indication Primary prevention of breast cancer in postmenopausal women at moderate or high risk. Supported by IBIS-II study and sponsored by NHS. Updates to SmPC sections 4.1, 4.2, 4.4, 4.8(ADR), and 5.1. Consequential updates to the PIL and RMP.
SmPC Sections updated: 4.1, 4.2, 4.4, 4.8, 5.1 and 10.
Last updated on this site: 09 Nov 2023
Description of update: Repurposing project to add indication Primary prevention of breast cancer in postmenopausal women at moderate or high risk. Supported by IBIS-II study and sponsored by NHS. Updates to SmPC sections 4.1, 4.2, 4.4, 4.8(ADR), and 5.1. Consequential updates to the PIL and RMP.
SmPC Sections updated: 4.1, 4.2, 4.4, 4.8, 5.1 and 10.
-
Changes: (Updated: 09 Nov 2023)
Description of update: Repurposing project to add indication Primary prevention of breast cancer in postmenopausal women at moderate or high risk. Supported by IBIS-II study and sponsored by NHS. Updates to SmPC sections 4.1, 4.2, 4.4, 4.8(ADR), and 5.1. Consequential updates to the PIL and RMP.
SmPC Sections updated: 4.1, 4.2, 4.4, 4.8, 5.1 and 10.
-
Changes: (Updated: 20 Sep 2022)
Linked to amended product entry
-
Changes: (Updated: 15 Sep 2022)
Initial upload
-
Changes: (Updated: 15 Sep 2022)
initial upload